Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

Comment: (RVd) ± , stem cell transplantation and R maintenance shows...

Dr Julie Gralow- Chief Medical Officer, ASCO

Comment: (RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients ( Dr Julie Gralow- Chief Medical Officer, ASCO )

Comment: Phase III assessment of topotecan, cyclophosphamide and high-dose...

Dr Julie Gralow- Chief Medical Officer, ASCO

$Comment: Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients ( Dr Julie Gralow- Chief Medical Officer, ASCO )$

Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast...

Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA

Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients ( Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA )

Review: Best options in localised prostate cancer

Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim...

Review: Best options in localised prostate cancer ( Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim Fizazi )

COMy 2022: Multiple myeloma roundup

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

COMy 2022: Multiple myeloma roundup ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )

Giving abatacept after checkpoint inhibitors can improve immunotherapy...

Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA

Giving abatacept after checkpoint inhibitors can improve immunotherapy responses in melanoma ( Dr Stephen Mok - The University of Texas MD Anderson Cancer Center, Houston, USA )

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2...

Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA

Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100 ( Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA )

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for...

Prof Nicolas Girard - Institut Curie, Paris, France

Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Advance Prostate Cancer Consensus Conference 2021: Report

Prof Silke Gillessen and Prof Aurelius Omlin

Advance Prostate Cancer Consensus Conference 2021: Report ( Prof Silke Gillessen and Prof Aurelius Omlin )

Biomedicine and the soul

Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada

Biomedicine and the soul ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )

Recent advances in the treatment of patients with exon 20 insertion-positive...

Dr Alfredo Addeo, Prof Nicolas Girard and Prof Natasha Leighl

Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC ( Dr Alfredo Addeo, Prof Nicolas Girard and Prof Natasha Leighl )

ASCO GU 2022: Prostate roundup

Prof Eleni Efstathiou, Prof Axel Merseburger and Dr Neal Shore

ASCO GU 2022: Prostate roundup ( Prof Eleni Efstathiou, Prof Axel Merseburger and Dr Neal Shore )

More from ecancer